Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients

计划入组 120 人 · 首次发布于 2025 年 2 月 18 日

Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients

计划入组 180 人 · 首次发布于 2025 年 8 月 26 日

Disparities in National Kidney Allocation Policy

计划入组 56,332 人 · 首次发布于 2016 年 8 月 26 日

chronic kidney disease therapy

Kidney bean

HuCo Kidney

Kidney & Hypertension Center

United States

Institute For Neurodegenerative Disorders

United States

NATIONAL KIDNEY AND TRANSPLANT INSTITUTE

Philippines

CDSCO Approves Novartis' Protocol Amendment for Iptacopan Study in Rare Kidney Disorders

Novo Nordisk Acquires Zaltenibart from Omeros for Up to $2.1 Billion to Target Rare Blood and Kidney Disorders

PYC Therapeutics Advances Novel Kidney Drug to First Human Clinical Trials